Gi-Sang Bae

Wonkwang University
Country flagSouth Korea

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

Year:

2026

Year:

2025

Objectives: This study utilized a network pharmacology approach to investigate the potential therapeutic effects and underlying mechanisms of Daehwangmokdanpi-tang (DHMDPT) in diabetic cognitive disorder (DCD).Methods: The compounds of DHMDPT and their target genes were obtained from the OASIS and PubChem databases. These putative target genes were compared with known targets of DCD to identify potential correlations. Using Cytoscape 3.10.2, a network was constructed to highlight key target genes. To further elucidate the underlying mechanisms, functional enrichment analysis was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Finally, CB-DOCK was used to assess binding affinities and confirm the interactions.Results: The results showed that a total of 27 compounds and 439 related genes were identified from DHMDPT. Among these, 373 genes interacted with the DCD gene set, indicating a close relationship between the effects of DHMDPT and DCD. Through GO enrichment analysis and KEGG pathways, ‘Regulation of Apoptotic Process’, ‘Cytokine-Mediated signaling pathway’, and ‘AGE-RAGE signaling pathway in diabetic complications’ were identified as the functional pathways of the 18 key target genes of DHMDPT on DCD. Additionally, molecular docking was performed to assess the binding affinities of the six most highly associated key target genes of DCD with active compounds.Conclusions: Using a network pharmacology approach, which included molecular docking, DHMDPT was found to be highly relevant to DCD. This study could serve as a foundation for further research on the cognitive enhancement effects of DHMDPT in DCD.

Year:

2024

Objectives: Puriton® is the electrolyte enriched water consisting of 31 essential minerals from biotite, kaolinite, montmorillonite, serpentine, and clinochlore, and vermiculite. It has been reported to be bactericidal and virucidal. However, the protective effect of Puriton® against acute pancreatitis (AP) has not yet been studied. Therefore, we aimed to evaluate the protective effect of Puriton® against cerulein-induced AP.Methods: AP was induced by intraperitoneal injections of cerulein (50 μg/kg) hourly for 6 times. Puriton® (100, 300, 500, or 700 μL) was administered orally 1 hour before the first cerulein injection. Mice were sacrificed 6 hours after the last cerulein injection. Pancreas, lung, and serum samples were quickly collected for further analysis.Results: Administration of Puriton® did not reduce the ratio of pancreas weight to body weight. However, the increased serum amylase and lipase were decreased in the Puriton® administration group, and histological damage to pancreas and lung tissue was suppressed in the Puriton® 100 and 300 μL administration groups, but not in the Puriton® 500 and 700 μL administration groups. Additionally, among pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, the mRNA level of only IL-6 was decreased by Puriton® administration.Conclusion: In summary, we showed that the administration of Puriton® improved the severity of cerulein-induced AP, suggesting the possibility of being an effective drug for AP.

Year:

2024

Objectives: Network pharmacology is an analysis method that explores drug-centered efficacy and mechanism by constructing a compound-target-disease network based on system biology, and is attracting attention as a methodology for studying herbal medicine that has the characteristics for multi-compound therapeutics. Thus, we investigated the potential functions and pathways of Myrrha on Allergic Rhinitis (AR) via network pharmacology analysis and molecular docking.Methods: Using public databases and PubChem database, compounds of Myrrha and their target genes were collected. The putative target genes of Myrrha and known target genes of AR were compared and found the correlation. Then, the network was constructed using STRING database, and functional enrichment analysis was conducted based on the Gene Ontology (GO) Biological process and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways. Binding-Docking stimulation was performed using CB-Dock.Results: The result showed that total 3 compounds and 55 related genes were gathered from Myrrha. 33 genes were interacted with AR gene set, suggesting that the effects of Myrrha are closely related to AR. Target genes of Myrrha are considerably associated with various pathways including ‘Fc epsilon RI signaling pathway’ and ‘JAK-STAT signaling pathway’. As a result of blinding docking, AKT1, which is involved in both mechanisms, had high binding energies for abietic acid and dehydroabietic acid, which are components of Myrrha.Conclusion: Through a network pharmacological method, Myrrha was predicted to have high relevance with AR by regulating AKT1. This study could be used as a basis for studying therapeutic effects of Myrrha on AR.

Year:

2024

Objectives: This study employed a network pharmacology approach to explore the potential therapeutic effects and underlying molecular mechanisms of Zizyphus jujuba Miller var. inermis Rehder (Jujube) in the treatment of chronic pancreatitis (CP).Methods: The bioactive compounds of Jujube and their target genes were identified from the HERB, OASIS databases. These putative target genes were then cross-referenced with CP-associated genes to identify potential correlations. A network was subsequently constructed using Cytoscape 3.10.2. To further investigate, functional enrichment analyses were conducted using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway databases. Additionally, binding affinities between active compounds and key genes were assessed by CB-DOCK2.Results: 55 active compounds and 344 associated target genes were identified from Jujube. Among these, 156 genes overlapped with the CP gene set. After screening, 9 key genes were identified from this subset, further emphasizing the significant relationship between the Jujube and CP. GO and KEGG analyses revealed that the 'PI3K-Akt Signaling Pathway' is a significant pathway mediated by 9 key genes in the context of CP. Furthermore, molecular docking analysis confirmed the strong binding affinities between the active compounds and key genes.Conclusions: Through the application of a network pharmacology approach, complemented by molecular docking studies, this research highlights a strong pharmacological relevance of Jujube in CP. These findings provide a valuable foundation for future investigations into the therapeutic potential of Jujube in mitigating CP, possibly through the modulation of the PI3K/Akt signaling pathway.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (2)

Jungtae Leem

professor

Wonkwang University

SOUTH KOREA
View details

Mi Hye Kim

Professor

Woosuk University

SOUTH KOREA
View details